EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-World Effectiveness of Boosting Against Omicron Hospitalization in Older Adults, Stratified by Frailty

Liang En Wee iD, Enoch Xue Heng Loy, Jue Tao Lim, Wei Hao Kwok, Calvin Chiew iD, Christopher Lien, Barbara Helen Rosario, Ian Yi Onn Leong, Reshma Aziz Merchant iD, David Chien Boon Lye iD, Kelvin Bryan Tan

Vaccines · 26.05.2025 · 13 (6) · 565

DOI: 10.3390/vaccines13060565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 26.05.2025. Verfasst von Liang En Wee und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Infectious Diseases, Singapore 308442, Singapore. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Older adults with frailty are at-risk of worse outcomes following respiratory-viral-infections such as COVID-19. Data on effectiveness of vaccination/boosting in frail older adults during Omicron is lacking.

Methods

National healthcare-claims data and COVID-19 registries were utilized to enroll a cohort of older Singaporeans (≥60 years) as of 1 January 2022, divided into low/intermediate/high-risk for frailty; matching weights were utilized to adjust for sociodemographic differences/vaccination uptake at enrolment across frailty categories. Competing-risk-regression (Fine-Gray) taking death as a competing risk, with matching weights applied, was utilized to compare risks of COVID-19-related hospitalizations and severe COVID-19 across frailty levels (low/intermediate/high-risk), with estimates stratified by booster status. Individuals were followed up until study end-date (20 December 2023).

Results

874,160 older adults were included during Omicron-predominant transmission; ~10% had intermediate/high-frailty-risk. Risk of hospitalization/severe COVID-19 was elevated in those with intermediate/high-frailty-risk up to XBB/JN.1 transmission. Boosting was associated with decreased risk of COVID-19-related hospitalization across all frailty categories in infection-naïve individuals. However, in infection-naïve older adults with high-frailty-risk, while receipt of first boosters was associated with lower risk of COVID-19-hospitalization/severe COVID-19, additional booster doses did not reduce risk. In reinfected older adults, first boosters were still associated with lower hospitalization risk (adjusted-hazards-ratio, aHR = 0.55, 95% CI = 0.33–0.92) among the non-frail, but not in the intermediate/high-frailty-risk minority.

Conclusions

First boosters were associated with reduced adverse COVID-19 outcomes across all frailty categories in infection-naïve older adults during Omicron. However, in the high-frailty minority, boosting did not additionally reduce risk in reinfected individuals with hybrid immunity, and beyond the first booster for infection-naïve individuals.

Schlagwörter

Stichwörter der Autor:innen

OmicronSARS-CoV-2boostingfrailtygeriatricsvaccination

Autor:innen und Institutionen

  • National Centre for Infectious Diseases, Singapore 308442, Singapore.
  • Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore.
  • Department of Infectious Diseases, Singapore General Hospital, Singapore 169608, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
  • Ministry of Health, Singapore 169854, Singapore.
  • Department of Geriatric Medicine, Changi General Hospital, Singapore 529889, Singapore.

ORCID-Profile: Liang En Wee, Calvin Chiew, Reshma Aziz Merchant, David Chien Boon Lye

Zitieren

APA

Wee, L. E., Loy, E. X. H., Lim, J. T., Kwok, W. H., Chiew, C., Lien, C., Rosario, B. H., Leong, I. Y. O., Merchant, R. A., Lye, D. C. B., & Tan, K. B. (2025). Real-World Effectiveness of Boosting Against Omicron Hospitalization in Older Adults, Stratified by Frailty. Vaccines, 13(6), 565. https://doi.org/10.3390/vaccines13060565

Vancouver

Wee LE, Loy EXH, Lim JT, Kwok WH, Chiew C, Lien C, et al. Real-World Effectiveness of Boosting Against Omicron Hospitalization in Older Adults, Stratified by Frailty. Vaccines. 2025;13(6):565. doi:10.3390/vaccines13060565

BibTeX
@article{Wee2025,
  author = {Wee, Liang En and Loy, Enoch Xue Heng and Lim, Jue Tao and Kwok, Wei Hao and Chiew, Calvin and Lien, Christopher and Rosario, Barbara Helen and Leong, Ian Yi Onn and Merchant, Reshma Aziz and Lye, David Chien Boon and Tan, Kelvin Bryan},
  title = {Real-World Effectiveness of Boosting Against Omicron Hospitalization in Older Adults, Stratified by Frailty},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {6},
  pages = {565},
  doi = {10.3390/vaccines13060565}
}
Kostenlos starten →